The FARAPULSE PersAFOne III Trial for the Treatment of Persistent Atrial Fibrillation
Clinical trial NCT05272852 · COMPLETED
Trial details
- NCT number
- NCT05272852
- Sponsor
- Boston Scientific Corporation
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-03
- Primary completion
- 2024-02-09
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.